Park Square is pleased to announce the placement of Michael Cox as Vice President, Clinical Development at Puma Biotechnology. Puma focuses on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seeks to further develop these drug candidates for commercial use.

Cox most recently held various roles at Loxo Oncology, including Senior Director, Pediatric Clinical Development; Senior Director, Clinical Development and Medical Affairs Global Development Lead, Larotrectinib Pediatric Development Program; and Director, Clinical Development and Medical Affairs. Previously, Cox served as European Medical Affairs Lead, Oncology Pipeline, Medical Affairs, Region Europe/Canada and Emerging Markets EMEA at Bayer HealthCare AG. 

Cox received his Pharm.D. from Ohio Northern University and his M.S. from Duke University. 

Park Square Executive Search serves companies and institutions that are shaping the world through discovery, innovation and growth. Our clients are leading life sciences and healthcare organizations, technology companies, major research universities, and venture capital and private equity firms, including their portfolio companies. We place board members, chief executive officers, C-suite executives, and academic leaders.